IL-10家族在肠纤维化中作用的研究进展

doi:10.13481/j.1671-587x.20170436

摘要/Abstract

摘要： 白细胞介素10（IL-10）家族是一类重要的多向分化的免疫调节因子，其作为组织重塑相关炎症因子在多种器官纤维化疾病的发生中发挥重要作用，近年来也作为抗纤维化因子在临床抗纤维化治疗中发挥作用。IL-10抗纤维化机制可能是通过保持上皮细胞完整性及组织修复发挥作用。本文作者从IL-10在肠纤维化中的作用及其目前的应用进行综述。

中图分类号:

R574

李辉, 魏民华, 张晓岚. IL-10家族在肠纤维化中作用的研究进展[J]. 吉林大学学报(医学版), 2017, 43(04): 849-851.

[1] Shelley-Fraser G, Borley NR, Warren BF, et al. The connective tissue changes of Crohn's disease[J]. Histopathology, 2012,60(7):1034-1044.
[2] Fiocchi C, Lund PK. Themes in fibrosis and gastrointestinal inflammation[J]. Am J Physiol Gastrointest Liver Physiol, 2011,300(5):G677-G683.
[3] Sziksz E, Pap D, Lippai R, et al. Fibrosis related inflammatory mediators:role of the IL-10 cytokine family[J]. Mediators Inflamm, 2015, 2015:764641.
[4] Hazlett LD, Jiang X, McClellan SA. IL-10 function, regulation, and in bacterial keratitis[J]. J Ocul Pharmacol Ther, 2014,30(5):373-380.
[5] Pestka S, Krause CD, Sarkar D, et al. Interleukin-10 and related cytokines and receptors[J]. Annu Rev Immunol, 2004, 22:929-979.
[6] Donnelly RP, Dickensheets H, Finbloom DS. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes[J]. J Interferon Cytokine Res, 1999,19(6):563-573.
[7] Mrowietz U, Seifert O. Keloid scarring:new treatments ahead[J]. Actas Dermosifiliogr, 2009, 100(Suppl 2):75-83.
[8] Kabel AM, Abd Elmaaboud MA, Atef A, et al. Ameliorative potential of linagliptin and/or calcipotriol on bleomycin-induced lung fibrosis:In vivo and in vitro study[J]. Environ Toxicol Pharmacol, 2017,50:216-226.
[9] Barbarin V, Petrek M, Kolek V, et al. Characterization of p40 and IL-10 in the BALF of patients with pulmonary sarcoidosis[J]. J Interferon Cytokine Res, 2003,23(8):449-456.
[10] Kucejko W, Chyczewska E, Naumnik W, et al. Concentration of surfactant protein D, Clara cell protein CC-16 and IL-10 in bronchoalveolar lavage (BAL) in patients with sarcoidosis, hypersensivity pneumonitis and idiopathic pulmonary fibrosis[J]. Folia Histochem Cytobiol, 2009,47(2):225-230.
[11] Abdalla AE, Lambert N, Duan X, et al. Interleukin-10 Family and Tuberculosis:An Old Story Renewed[J]. Int J Biol Sci, 2016,12(6):710-717.
[12] Jennings P, Crean D, Aschauer L, et al. Interleukin-19 as a translational indicator of renal injury[J]. Arch Toxicol, 2015,89(1):101-106.
[13] Xie J, Li X, Meng D, et al. Transduction of interleukin-10 through renal artery attenuates vascular neointimal proliferation and infiltration of immune cells in rat renal allograft[J]. Immunol Lett, 2016,176:105-113.
[14] Jin Y, Liu R, Xie J, et al. Interleukin-10 deficiency aggravates kidney inflammation and fibrosis in the unilateral ureteral obstruction mouse model[J]. Lab Invest, 2013,93(7):801-811.
[15] Chen WC, Lee BG, Park DW, et al. Controlled dual delivery of fibroblast growth factor-2 and interleukin-10 by heparin-based coacervate synergistically enhances ischemic heart repair[J]. Biomaterials, 2015,72:138-151.
[16] Kondo H, Takahashi N, Gotoh K, et al. Splenectomy exacerbates atrial inflammatory fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats:Possible role of spleen-derived interleukin-10[J]. Heart Rhythm, 2016,13(1):241-250.
[17] Nobili V, Alkhouri N, Alisi A, et al. Nonalcoholic fatty liver disease:a challenge for pediatricians[J]. JAMA Pediatr, 2015,169(2):170-176.
[18] Khawar MB, Azam F, Sheikh N, et al. How does interleukin-22 mediate liver regeneration and prevent injury and fibrosis?[J]. J Immunol Res, 2016, 2016:2148129.
[19] Hung KS, Lee TH, Chou WY, et al. Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice[J]. Biochem Biophys Res Commun, 2005,336(1):324-331.
[20] Fonseca-Camarillo G, Furuzawa-Carballeda J, Lorente L, et al. IL-10 and IL-20 expressing epithelial and inflammatory cells are increased in patients with ulcerative colitis[J]. J Clin Immunol, 2013,33(3):640-648.
[21] Santaolalla R, Mañé J, Pedrosa E, et al. Apoptosis resistance of mucosal lymphocytes and IL-10 deficiency in patients with steroid-refractory Crohn's disease[J]. Inflamm Bowel Dis, 2011,17(7):1490-1500.
[22] Guo X,Li MG,Li SS,et al. Tumor necrosis factor suppresses interleukin-10 in peripheral B cells via upregulating Bcl2-like protein 12 in patients with inflammatory bowel disease[J].Cell Biochem Funct,2017,35(2):77-82.
[23] Correa I, Veny M, Esteller M, et al. Defective IL-10 production in severe phenotypes of Crohn's disease[J]. J Leukoc Biol, 2009,85(5):896-903.
[24] Matsuo Y, Azuma YT, Kuwamura M, et al. Interleukin 19 reduces inflammation in chemically induced experimental colitis[J]. Int Immunopharmacol, 2015,29(2):468-475.
[25] Azuma YT, Matsuo Y, Kuwamura M, et al. Interleukin-19 protects mice from innate-mediated colonic inflammation[J]. Inflamm Bowel Dis, 2010,16(6):1017-1028.
[26] Yamamoto-Furusho JK, Alvarez-León E, Fragoso JM, et al. Protective role of interleukin-19 gene polymorphisms in patients with ulcerative colitis[J]. Hum Immunol, 2011,72(11):1029-1032.
[27] Rutz S, Wang X, Ouyang W. The IL-20 subfamily of cytokines——from host defence to tissue homeostasis[J]. Nat Rev Immunol, 2014,14(12):783-795.
[28] Elson CO, Cong Y, Weaver CT, et al. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice[J]. Gastroenterology, 2007,132(7):2359-2370.
[29] Pickert G, Neufert C, Leppkes M, et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing[J]. J Exp Med, 2009,206(7):1465-1472.
[30] Yu LZ, Wang HY, Yang SP, et al. Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis[J]. World J Gastroenterol, 2013,19(17):2638-2649.
[31] Fonseca-Camarillo G, Furuzawa-Carballeda J, Granados J, et al. Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients:a cross-sectional study[J]. Clin Exp Immunol, 2014,177(1):64-75.
[32] Troncone E, Marafini I, Pallone F, et al. Th17 cytokines in inflammatory bowel diseases:discerning the good from the bad[J]. Int Rev Immunol, 2013,32(5/6):526-533.
[33] Balaji S,Wang X,King A,et al.Interleukin-10-mediated regenerative postnatal tissue repair is dependent on regulation of hyaluronan metabolism via fibroblast-specific STAT3 signaling[J].FASEB J, 2017, 31(3):868-881.
[34] Li MC, He SH. IL-10 and its related cytokines for treatment of inflammatory bowel disease[J]. World J Gastroenterol, 2004,10(5):620-625.
[35] Marlow GJ, van Gent D, Ferguson LR. Why interleukin-10 supplementation does not work in Crohn's disease patients[J]. World J Gastroenterol, 2013,19(25):3931-3941.

IL-10家族在肠纤维化中作用的研究进展

Research progress in role of IL-10 cytokine family in intestinal fibrosis

RichHTML

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	白洁, 纪文静, 丁永年, 彭媛媛, 陈源文. 胆总管结扎致肝纤维化模型大鼠肝脏内源性AcSDKP及其调控因子水平的变化[J]. 吉林大学学报(医学版), 2018, 44(05): 999-1004.
[2]	石旭, 余欣, 曲兴龙, 曹扬, 张广娟, 李长远. 低氧及其下游因子miRNA-145在脐带间充质干细胞向Ⅱ型肺泡上皮细胞分化中的作用[J]. 吉林大学学报(医学版), 2018, 44(05): 935-942.
[3]	王军, 赵卫红, 边鹊桥, 王保占. 不同临床分期湿疹患者外周血中IL-7和IL-10水平变化及其临床意义[J]. 吉林大学学报(医学版), 2018, 44(03): 553-557.
[4]	戴惠咛, 吕帅, 王德利, 李丹, 张师桃, 刘嘉凝, 刘阳, 刘小波, 李婉南. 葵花盘粉有效成分对小鼠高尿酸血症的治疗作用[J]. 吉林大学学报(医学版), 2018, 44(02): 327-331.
[5]	庞春艳, 王慧, 王志华, 冯秀媛, 王永福. 腺病毒介导的“睡美人”转座子与IL-10共表达对NOD小鼠Th17/Treg细胞平衡的影响[J]. 吉林大学学报(医学版), 2018, 44(02): 205-210.
[6]	王丽萍, 王建辉, 李树民, 杨秀红. N-乙酰半胱氨酸通路对AGT-REN双转基因高血压小鼠心肌成纤维细胞中电导钙激活钾离子通道蛋白表达的影响及其意义[J]. 吉林大学学报(医学版), 2017, 43(05): 881-886.
[7]	牛猛, 邓大勇, 李云鹏飞, 刘硕, 丁军. 磁共振弹性成像对肝纤维化分级诊断价值的Meta分析[J]. 吉林大学学报(医学版), 2017, 43(04): 787-793.
[8]	刘红梅, 初喆, 田锐, 唐颖. IL-10和IL-12检测在结核性和恶性胸腔积液鉴别诊断中的应用[J]. 吉林大学学报(医学版), 2017, 43(04): 782-786.
[9]	赵丽晶, 康晶, 安英, 徐博, 王艳春. 鸢尾黄素对大鼠心肌纤维化的作用及其机制[J]. 吉林大学学报(医学版), 2017, 43(02): 288-292.
[10]	潘军强, 张殿新, 孙超峰, 杨进. 微纤维蛋白1在瓣膜性心房颤动患者心房组织中的表达及其与心房纤维化的关系[J]. 吉林大学学报(医学版), 2017, 43(02): 339-343.
[11]	常彩芳, 候勇, 丛刚. α-2b干扰素对乙型肝炎模型鸭肝组织炎症和肝纤维化的治疗作用[J]. 吉林大学学报(医学版), 2017, 43(01): 11-15.
[12]	邓海月, 于方, 姜红. 直接肾素抑制剂阿利吉仑对肾纤维化小鼠上皮-间质转化的调节作用[J]. 吉林大学学报(医学版), 2017, 43(01): 16-20.
[13]	谭婧瑾, 王瑞民, 姜杉, 姚月, 陈洋, 王珂. FGFR信号传导通路在特发性肺纤维化和非小细胞肺癌发病中作用机制的研究进展[J]. 吉林大学学报(医学版), 2016, 42(06): 1254-1258.
[14]	勾向博, 郭静, 白静. 荞麦花叶总黄酮对2型糖尿病大鼠心肌纤维化的保护作用及其机制[J]. 吉林大学学报(医学版), 2016, 42(04): 694-698.
[15]	王艳, 王瑞民, 张庆华, 王珂. 间质性肺疾病与肺癌发病关联性的研究进展[J]. 吉林大学学报(医学版), 2016, 42(04): 830-834.